AnaptysBio (ANAB) Financials: Revenue & Earnings

ANAB price $50.11 +0.48 +0.97%

Ticker
ANAB
Price
$50.11
Change
+0.48 +0.97%
Market cap ?
$1.50B
P/E ?
7.23
Forward P/E ?
9.88
Dividend yield ?
0.00%
Beta ?
0.41
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
78
Value
62
Quality
72
Growth
100

Stocklytics score rationale: value 62, quality 72, growth 100.

Financials

2016201720182019202020212022202320242025
1668400010000000500000080000007500000063175000102870001715700091280000234603000

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company’s products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease…

Fair value

ANAB fair value $352.94. Price $50.11. Price is 86% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare ANAB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-1.84—25.56M
2026-09-215.115.1127.49M27.49M
2026-05-12-1.84-0.3225.56M18.86M
2026-03-031.580.89108.25M87.04M
2025-11-040.52-1.0676.32M21.92M
2025-08-07-1.34-1.5022.26M11.68M
2025-05-05-1.28-1.3027.77M15.27M
2025-02-27-0.72-1.5543.11M7.78M
2024-11-05-1.14-1.6530.02M8.21M
2024-08-05-1.71-0.9910.97M22.76M
2024-05-09-1.64-1.577.18M4.00M
2024-03-12-1.59-1.609.01M3.79M
2023-11-02-1.41-1.793.32M2.29M
2023-08-07-1.50-1.703.46M2.68M
2023-05-11-1.58-1.051.37M2.90M
2023-03-01-0.93-0.966.81M5.78M
2022-11-08-1.18-0.721.29M13.43M
2022-08-08-1.15-1.021.22M5.30M
2022-05-04-1.31-0.99970.00K5.05M
2022-03-07-1.132.571.01M976.00K
2021-11-04-0.24-0.7420.89M7.60M
2021-08-09-0.02-0.1130.03M28.88M
2021-05-04-0.66-0.6911.25M9.50M
2021-02-251.201.3960.00M55.00M
2020-11-04-0.87-0.72—2.00M
2020-08-10-0.79-0.75—2.32M
2020-05-06-0.30-0.6315.00M31.50M
2020-03-02-0.75-1.203.00M4.80M
2019-11-08-1.15-1.15—3.50M
2019-08-08-0.89-0.995.00M5.56M
2019-05-07-0.82-0.83——
2019-02-28-0.64-0.92——
2018-11-08-0.66-0.715.00M5.38M
2018-08-07-0.57-0.70——
2018-05-08-0.63-0.43——
2018-03-05-0.30-0.423.00M4.20M
2017-11-07-0.45-0.48——
2017-08-10-0.13-0.457.00M24.23M
2017-05-11-0.75-0.18——
2017-03-08-1.73-0.102.75M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01RENTON HOLLINGSBuy5.00K$18.0390.15K
2026-10-01RENTON HOLLINGSSell5.00K$49.87249.37K
2026-10-01RENTON HOLLINGSSell5.00K$18.0390.15K
2026-09-15Orwin John ABuy1.30K——
2026-09-15Orwin John ASell1.30K——
2026-06-15Schmid John P.Buy6.03K——
2026-06-15Schmid John P.Sell6.03K——
2026-06-15RENTON HOLLINGSBuy6.03K——
2026-06-15RENTON HOLLINGSSell6.03K——
2026-06-15Orwin John ABuy6.03K——
2026-06-15Orwin John ASell6.03K——
2026-05-11Hughes OwenBuy11.25K——
2026-05-11Hughes OwenOther0——
2026-05-11Murphy Christopher M.Buy25.77K——
2026-05-11Murphy Christopher M.Other0——
2026-04-27GRAY SUSANNAHBuy11.25K——
2026-04-20Faga DanielSell11.00K$31.12342.32K
2026-04-20Orwin John ABuy16.51K$15.53256.40K
2026-04-20Orwin John ASell16.51K$21.19349.85K
2026-04-20Orwin John ASell16.51K$14.83244.84K
2026-04-20Orwin John ABuy16.51K$10.87179.46K
2026-04-20Orwin John ABuy10.60K$14.29151.47K
2026-04-20Orwin John ASell10.60K$19.50206.70K
2026-04-20Orwin John ASell8.25K$43.91362.26K
2026-04-20Orwin John ABuy8.25K$32.17265.40K
2026-04-20Orwin John ABuy3.31K$14.2947.31K
2026-04-20Orwin John ASell3.31K$19.5064.56K
2026-04-20Schmid John P.Buy16.51K$10.87179.46K
2026-04-20Schmid John P.Sell16.51K$21.19349.85K
2026-04-20Schmid John P.Buy16.51K$15.53256.40K
2026-04-20Schmid John P.Sell16.51K$14.83244.84K
2026-04-20Schmid John P.Buy15.00K$18.03270.45K
2026-04-20Schmid John P.Sell15.00K$24.60369.00K
2026-04-20Schmid John P.Buy11.00K$12.14133.54K
2026-04-20Schmid John P.Sell11.00K$29.70326.70K
2026-04-20Schmid John P.Buy11.00K$21.76239.36K
2026-04-20Schmid John P.Sell11.00K$16.56182.16K
2026-04-20Schmid John P.Sell10.60K$23.23246.24K
2026-04-20Schmid John P.Buy10.60K$17.02180.41K
2026-04-20Schmid John P.Sell9.20K$30.44280.05K
2026-04-20Schmid John P.Buy9.20K$22.13203.60K
2026-04-20Schmid John P.Buy6.00K$76.79460.74K
2026-04-20Schmid John P.Buy6.00K$50.47302.82K
2026-04-20Schmid John P.Sell6.00K$104.81628.86K
2026-04-20Schmid John P.Sell6.00K$68.88413.28K
2026-04-20Schmid John P.Sell5.50K$43.91241.50K
2026-04-20Schmid John P.Buy5.50K$32.17176.94K
2026-04-20RENTON HOLLINGSBuy16.51K$15.53256.40K
2026-04-20RENTON HOLLINGSSell16.51K$21.19349.85K
2026-04-20RENTON HOLLINGSBuy16.51K$10.87179.46K
2026-04-20RENTON HOLLINGSSell16.51K$14.83244.84K
2026-04-20RENTON HOLLINGSSell15.00K$24.60369.00K
2026-04-20RENTON HOLLINGSBuy15.00K$18.03270.45K
2026-04-20RENTON HOLLINGSSell11.00K$16.56182.16K
2026-04-20RENTON HOLLINGSBuy11.00K$12.14133.54K
2026-04-20RENTON HOLLINGSSell11.00K$29.70326.70K
2026-04-20RENTON HOLLINGSBuy11.00K$21.76239.36K
2026-04-20RENTON HOLLINGSBuy10.60K$17.02180.41K
2026-04-20RENTON HOLLINGSSell10.60K$23.23246.24K
2026-04-20RENTON HOLLINGSBuy9.20K$22.13203.60K
2026-04-20RENTON HOLLINGSSell9.20K$30.44280.05K
2026-04-20RENTON HOLLINGSSell6.00K$68.88413.28K
2026-04-20RENTON HOLLINGSSell6.00K$104.81628.86K
2026-04-20RENTON HOLLINGSBuy6.00K$76.79460.74K
2026-04-20RENTON HOLLINGSBuy6.00K$50.47302.82K
2026-04-20RENTON HOLLINGSSell5.50K$43.91241.50K
2026-04-20RENTON HOLLINGSBuy5.50K$32.17176.94K
2026-04-20Faga DanielBuy379.62K$15.535.90M
2026-04-20Faga DanielSell379.62K$21.198.04M
2026-04-20Faga DanielSell305.50K$14.834.53M
2026-04-20Faga DanielBuy305.50K$10.873.32M
2026-04-20Faga DanielBuy194.90K$17.023.32M
2026-04-20Faga DanielSell194.90K$23.234.53M
2026-04-20Faga DanielBuy133.40K$32.174.29M
2026-04-20Faga DanielSell133.40K$43.915.86M
2026-04-20Faga DanielSell11.00K$31.12342.32K
2026-04-20Faga DanielBuy11.00K$22.80250.80K
2026-04-20Faga DanielSell9.20K$30.44280.05K
2026-04-20Faga DanielBuy9.20K$22.31205.25K
2026-04-20Faga DanielBuy2.32K$22.8052.92K
2026-04-20Faga DanielSell2.32K$31.1272.23K
2026-03-30Schmid John P.Sell12.60K$55.71701.71K
2026-03-30Schmid John P.Sell7.53K$56.70426.78K
2026-03-30Schmid John P.Sell522$57.4029.96K
2026-03-27Faga DanielSell510$56.6128.87K
2026-03-27Faga DanielSell2.57K$57.91148.82K
2026-03-27Faga DanielSell3.66K$58.62214.65K
2026-03-27Faga DanielSell490$59.6229.22K
2026-03-27Faga DanielSell550$60.6333.34K
2026-03-27Faga DanielSell1.01K$62.1562.90K
2026-03-27Faga DanielSell2.59K$63.35164.20K
2026-03-27Faga DanielSell3.15K$64.19202.52K
2026-03-27Faga DanielSell3.04K$65.20198.07K
2026-03-27Faga DanielSell100$65.996.60K
2026-03-26GRAY SUSANNAHOther0——
2026-03-25Faga DanielBuy34.30K——
2026-03-12Lizzul Paul F.Buy16.67K——
2026-03-12Faga DanielBuy53.33K——
2026-02-11LOUMEAU ERIC JSell10.00K$29.70297.00K
2026-02-11LOUMEAU ERIC JBuy10.00K$29.70297.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 221, holders +10 vs prior quarter. Ownership 105.73%.

HolderSharesChangeChange %Value
ECOR1 CAPITAL, LLC7.88M00.00%531.91M
BLACKROCK, INC.1.84M162.67K+9.67%124.47M
TANG CAPITAL MANAGEMENT LLC1.33M00.00%89.83M
STATE STREET CORP1.29M293.75K+29.60%86.82M
VANGUARD CAPITAL MANAGEMENT LLC906.23K53.08K+6.22%61.17M
AFFINITY ASSET ADVISORS, LLC826.11K-113.89K-12.12%55.76M
SANOFI821.92K00.00%55.48M
MILLENNIUM MANAGEMENT LLC807.32K331.74K+69.76%54.49M
WOODLINE PARTNERS LP717.01K372.76K+108.28%48.40M
683 CAPITAL MANAGEMENT, LLC660.00K35.00K+5.60%44.55M
GEODE CAPITAL MANAGEMENT, LLC637.87K117.63K+22.61%43.06M
PALO ALTO INVESTORS LP603.49K-34.67K-5.43%40.74M
GOLDMAN SACHS GROUP INC584.07K251.33K+75.53%39.42M
FIRST LIGHT ASSET MANAGEMENT, LLC582.00K16.57K+2.93%39.29M
D. E. SHAW & CO., INC.539.67K-39.63K-6.84%36.43M
VANGUARD PORTFOLIO MANAGEMENT LLC527.86K7.99K+1.54%35.63M
APIS CAPITAL ADVISORS, LLC497.00K259.00K+108.82%33.55M
SOFINNOVA INVESTMENTS, INC.493.54K245.28K+98.80%33.31M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP488.65K-3.47K-0.70%32.98M
NUVEEN, LLC420.66K104.60K+33.09%28.39M
BANK OF AMERICA CORP /DE/417.81K-83.27K-16.62%28.20M
CITADEL ADVISORS LLC394.37K160.92K+68.93%26.62M
FEDERATED HERMES, INC.391.67K27.55K+7.57%26.44M
SQUAREPOINT OPS LLC324.45K56.74K+21.20%21.90M
TWO SIGMA INVESTMENTS, LP263.00K-202.09K-43.45%17.75M

Earnings and financials

AnaptysBio, Inc. (ANAB) trades at $50.11, with a market cap of $1.50B and a trailing P/E of 7.23. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
1668400010000000500000080000007500000063175000102870001715700091280000234603000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

AnaptysBio (ANAB) Financials: Revenue & Earnings

ANAB$50.11+0.48 +0.97%

$1.50B

Market Cap

7.23

P/E

9.88

Forward P/E

78

Score

Price History